Literature DB >> 21454680

Mitogen-activated protein kinase kinase 1 (MEK1) stabilizes MyoD through direct phosphorylation at tyrosine 156 during myogenic differentiation.

Chulman Jo1, Sun-Jung Cho, Sangmee Ahn Jo.   

Abstract

Previously, we reported that mitogen-activated protein kinase kinase 1 (MEK1) activated in the mid-stage of skeletal muscle differentiation promotes myogenic differentiation. To elucidate the molecular mechanism, we investigated an activity of MEK1 for MyoD. Activated MEK1 associates with MyoD in the nucleus of differentiating myoblasts. In vitro kinase assay using active MEK1, a (32)P-labeled protein band corresponding to GST-MyoD was observed but not to mutant GST-MyoD-Y156F. Tyrosine phosphorylation of endogenous MyoD was detected with a specific anti-pMyoD-Y156 antibody; however, this response was blocked by PD184352, a MEK-specific inhibitor. These results indicate that activated MEK1 phosphorylates the MyoD-Y156 residue directly. Interestingly, the protein level of mutant MyoD-Y156F decreased compared with that of wild type but was recovered in the presence of lactacystin, a proteasome inhibitor. The protein level of MyoD-Y156E, which mimics phosphorylation at Tyr-156, was above that of wild type, indicating that the phosphorylation protects MyoD from the ubiquitin proteasome-mediated degradation. In addition, the low protein level of MyoD-Y156F was recovered over that of wild type by an additional mutation at Leu-164, a critical binding residue of MAFbx/AT-1, a Skp, Cullin, F-box (SCF) E3-ubiquitin ligase. The amount of MyoD co-precipitated with MAFbx/AT-1 also was reduced in the presence of active MEK1. Thus, these results suggested that the phosphorylation probably interrupts the binding of MAFbx/AT-1 to MyoD and thereby increases its stability. Collectively, our results suggest that MEK1 activated in differentiating myoblasts stimulates muscle differentiation by phosphorylating MyoD-Y156, which results in MyoD stabilization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454680      PMCID: PMC3099706          DOI: 10.1074/jbc.M111.225128

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

Authors:  N H Chehab; A Malikzay; E S Stavridi; T D Halazonetis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications.

Authors:  P L Puri; V Sartorelli
Journal:  J Cell Physiol       Date:  2000-11       Impact factor: 6.384

Review 3.  Skeletal muscle formation in vertebrates.

Authors:  M Buckingham
Journal:  Curr Opin Genet Dev       Date:  2001-08       Impact factor: 5.578

4.  Mutation of MyoD-Ser237 abolishes its up-regulation by c-Mos.

Authors:  K Pelpel; M Leibovitch; A Fernandez; S A Leibovitch
Journal:  FEBS Lett       Date:  2000-06-02       Impact factor: 4.124

5.  A conserved docking motif in MAP kinases common to substrates, activators and regulators.

Authors:  T Tanoue; M Adachi; T Moriguchi; E Nishida
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

Review 6.  The MEK/ERK cascade: from signaling specificity to diverse functions.

Authors:  Yoav D Shaul; Rony Seger
Journal:  Biochim Biophys Acta       Date:  2006-10-19

7.  Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins.

Authors:  J L Lenormand; B Benayoun; M Guillier; M Vandromme; M P Leibovitch; S A Leibovitch
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

Review 8.  The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy.

Authors:  A J Murton; D Constantin; P L Greenhaff
Journal:  Biochim Biophys Acta       Date:  2008-10-29

9.  MEK1 plays contrary stage-specific roles in skeletal myogenic differentiation.

Authors:  Chulman Jo; Bong Geom Jang; Sangmee Ahn Jo
Journal:  Cell Signal       Date:  2009-09-03       Impact factor: 4.315

10.  Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.

Authors:  Julie Lagirand-Cantaloube; Karen Cornille; Alfredo Csibi; Sabrina Batonnet-Pichon; Marie Pierre Leibovitch; Serge A Leibovitch
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

View more
  13 in total

1.  The Intellectual Disability and Schizophrenia Associated Transcription Factor TCF4 Is Regulated by Neuronal Activity and Protein Kinase A.

Authors:  Mari Sepp; Hanna Vihma; Kaja Nurm; Mari Urb; Stephanie Cerceo Page; Kaisa Roots; Anu Hark; Brady J Maher; Priit Pruunsild; Tõnis Timmusk
Journal:  J Neurosci       Date:  2017-09-26       Impact factor: 6.167

2.  Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein.

Authors:  Candace Bichsel; Dennis Neeld; Takashi Hamazaki; Lung-Ji Chang; Li-Jun Yang; Naohiro Terada; Shouguang Jin
Journal:  Cell Reprogram       Date:  2013-02-25       Impact factor: 1.987

3.  Nuclear translocation of MEK1 triggers a complex T cell response through the corepressor silencing mediator of retinoid and thyroid hormone receptor.

Authors:  Lei Guo; Chaoyu Chen; Qiaoling Liang; Mohammad Zunayet Karim; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2012-12-05       Impact factor: 5.422

4.  Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders.

Authors:  Jianping Hu; Jieli Wei; Hyerin Yim; Li Wang; Ling Xie; Margaret S Jin; Md Kabir; Lihuai Qin; Xian Chen; Jing Liu; Jian Jin
Journal:  J Med Chem       Date:  2020-12-07       Impact factor: 7.446

5.  Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma.

Authors:  C M M Prado; T Bekaii-Saab; L A Doyle; S Shrestha; S Ghosh; V E Baracos; M B Sawyer
Journal:  Br J Cancer       Date:  2012-04-17       Impact factor: 7.640

6.  Differential contribution of hypothalamic MAPK activity to anxiety-like behaviour in virgin and lactating rats.

Authors:  Benjamin Jurek; David A Slattery; Rodrigue Maloumby; Katharina Hillerer; Sophie Koszinowski; Inga D Neumann; Erwin H van den Burg
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

7.  Direct binding of MEK1 and MEK2 to AKT induces Foxo1 phosphorylation, cellular migration and metastasis.

Authors:  Shiri Procaccia; Merav Ordan; Izel Cohen; Sarit Bendetz-Nezer; Rony Seger
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

8.  Mechanical Stimulation of Adhesion Receptors Using Light-Responsive Nanoparticle Actuators Enhances Myogenesis.

Authors:  Allison N Ramey-Ward; Hanquan Su; Khalid Salaita
Journal:  ACS Appl Mater Interfaces       Date:  2020-07-29       Impact factor: 9.229

9.  SCF(Fbxw15) mediates histone acetyltransferase binding to origin recognition complex (HBO1) ubiquitin-proteasomal degradation to regulate cell proliferation.

Authors:  Chunbin Zou; Yan Chen; Rebecca M Smith; Courtney Snavely; Jin Li; Tiffany A Coon; Bill B Chen; Yutong Zhao; Rama K Mallampalli
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.486

10.  Intrinsically active MEK variants are differentially regulated by proteinases and phosphatases.

Authors:  Merav Ordan; Chiara Pallara; Galia Maik-Rachline; Tamar Hanoch; Francesco Luigi Gervasio; Fabian Glaser; Juan Fernandez-Recio; Rony Seger
Journal:  Sci Rep       Date:  2018-08-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.